Capricor Therapeutics, Inc. CAPR
8.24 USD +1.00 (+13.81%)
At closeNov 3, 2026, 4:03 PM EST
8.26 +0.02 +0.24%
After hours · Nov 3, 4:03 PM ET
7.15 Day range 8.32
2.96 52-week range 40.37
- YTD
- -71.45%
- 1 year
- +35.75%
Analyst view
Consensus: strong buy
Strong buy
Price target (mean) 53.60 +550.5% upside
Now 8.24
- Target (low)
- 38.00
- Target (mean)
- 53.60
- Target (high)
- 63.00
Ratings (0m) 10 10 buy · 0 hold · 0 sell
- Strong buy2
- Buy8
- Hold0
- Sell0
- Strong sell0
Recommendation trend
- This month 10
- 1 month ago 10
- 2 months ago 9
- 3 months ago 9
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -0.59333 | -0.64 – -0.47 | -0.57 | -4.1% | 0 | 0.0% | 9 |
| Next quarter | 0.34556 | -0.67 – 2.56 | -0.54 | +164.0% | 53.53M | 0.0% | 9 |
| Current year | -0.22222 | -2.52 – 1.70 | -2.26 | +90.2% | 118.08M | 0.0% | 9 |
| Next year | -0.64222 | -2.57 – 0.62 | -0.22222 | -189.0% | 122.34M | +3.6% | 9 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| May 13, 2026 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Mar 13, 2026 | B. Riley Securities | Maintained | Buy | Buy |
| Mar 13, 2026 | Piper Sandler | Reiterated | Overweight | Overweight |
| Mar 13, 2026 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Mar 10, 2026 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Dec 15, 2025 | B. Riley Securities | Reiterated | Buy | Buy |
| Dec 10, 2025 | Piper Sandler | Reiterated | Overweight | Overweight |
| Dec 8, 2025 | Oppenheimer | Maintained | Outperform | Outperform |
| Dec 4, 2025 | Maxim Group | Maintained | Buy | Buy |
| Dec 3, 2025 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Nov 12, 2025 | Roth Capital | Maintained | Buy | Buy |
| Sep 25, 2025 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Sep 11, 2025 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Jul 14, 2025 | Roth Capital | Maintained | Buy | Buy |
| Jul 11, 2025 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Jun 26, 2025 | B. Riley Securities | Initiated | — | Buy |
| Jun 25, 2025 | Jones Trading | Maintained | Buy | Buy |
| Jun 24, 2025 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Jun 23, 2025 | Oppenheimer | Maintained | Outperform | Outperform |
| Jun 17, 2025 | Roth Capital | Reiterated | Buy | Buy |
| Jun 13, 2025 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| May 14, 2025 | Cantor Fitzgerald | Reiterated | Overweight | Overweight |
| Mar 20, 2025 | Cantor Fitzgerald | Reiterated | Overweight | Overweight |
| Mar 20, 2025 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Mar 17, 2025 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Mar 4, 2025 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Jan 2, 2025 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Nov 18, 2024 | Jones Trading | Initiated | — | Buy |
| Nov 14, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Nov 14, 2024 | Cantor Fitzgerald | Maintained | Overweight | Overweight |